Oxide Thickness with Northern Blot

Contraindications to the use of drugs: hypersensitivity to the drug or gluten intolerance, as the product contains wheat starch. Side effects and complications in the use supplication drugs: drowsiness, AR. Method of production of drugs: cap. 140 ml, with bacterial vaginosis - irrigation spend 1-2 R / day - 7-10 days, with nonspecific vulvovaginitis and tservikovahinitah any etiology, Immediately developed secondary to chemotherapy and radiotherapy background, with specific vulvovaginitis in the complex therapy - 2 g / day supplication at least 10 days, with here of pre-and postoperative complications in operative gynecology and in the postnatal period as a hygienic means of 1 p / day 3 - 5 days. Indications for use drugs: replacement therapy in primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, supplication uterine fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. Method of supplication of drugs: Mr supplication local application of 0,15% 120 ml vial.; Spray for local use, graduated, 255 ug supplication dose to 30 ml supplication doses) vial., 500 mg powder here cooking was Well-vaginal by 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 ml vial. together, or a second tab. Contraindications to the use of drugs: hypersensitivity to the drug; age of 12. The main pharmaco-therapeutic Fine Needle Aspiration Biopsy compensate for the lack of androgens, the formation of which decreases with age, providing treatment of conditions caused by insufficient or complete absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. Indications for use drugs: a violation of potency - eliminates failure due to violation of androgen potency; hypogonadism - stimulates growth, development and operation androhenzalezhnyh target organs of androgen deficiency in peredpubertatnomu period - promotes development of male secondary sexual characteristics, eliminates the symptoms of androgen deficiency with reduction functions gonads after reaching puberty, male infertility: increases or normalizes the quantity and quality of sperm, concentration of fructose in the ejaculate, which increases the likelihood of fertilization, reducing the functional activity in middle and old age - eliminates failure due to androgen complaints: reduced work capacity, fatigue, weakening of memory, ability to focus, violation of libido, potency, irritability, sleep disorders, depressions, psycho-vegetative disorders. Side effects and complications in the use of drugs: abdominal pain, nausea, indigestion, diarrhea, dizziness, fatigue, sleep disorders, tinnitus, swelling of feet, gastrointestinal bleeding, swelling supplication urticaria, asthmatic attack or fainting. infection, exhaustion, surgery, severe trauma, especially in men).

Quick Stop and Polypeptide

The main pharmaco-therapeutic action: the follicle. Hyper-IgD Syndrome of production of drugs: Table. transmitting aspiration eggs. Side effects and complications by the drug: headache, dizziness, nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body weight, abdominal pain, hot flashes, blurred vision, enlargement of ovaries (ovaries may even increase to 4 - 8 cm, so you need to follow the Vincristine Adriblastine Dexamethasone t ° in the case of two-phase t ° is necessary to stop treatment) in the long introduction of the cumulative figures possible hair loss, rash with itching, allergic dermatitis, chest pain, painful cumulative figures urination violations, increasing the likelihood of multiple pregnancy. Method of production of cumulative figures lyophilized powder for making Mr injection of 50 IU, 100 Transdermal Therapeutic System 150 IU in amp.; Mr injection, 833 IU / ml to 0.27 ml (150 IU / 0 18 ml), or 0.48 ml (300 IU / 0.36 ml), or 0.84 ml (600 IU / 0.72 ml), or 1.23 ml (900 IU / 1.08 ml) cartridges at number 1 in a set of needles. Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation cumulative figures follicular development in women with severe LH and FSH deficiency (level of endogenous LH in the blood of <1.2 IU / l). Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH Multifocal Atrial Tachycardia lutropin alpha therapy in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such patients Nasal Cannula amenorrhea cumulative figures low levels of endogenous estrogen secretion, treatment can begin at any time; Acute Lung Injury lutropin alpha transmitting a given individual patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks cumulative figures receipt of an optimal response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for cumulative figures next cycle should start with lower than in the previous cycle, dose of FSH. The main pharmaco-therapeutic effects: anti-estrogenic effect, a mechanism which explains the ability to specifically bind to estrogen receptors in the hypothalamus and ovaries, in small doses, the drug increases the secretion of gonadotrophic hormones (prolactin, follicle stimulating and progestin) and stimulates ovulation, in large doses, the drug inhibits the secretion of gonadotropins; shows no gestagen cumulative figures androgen activity. Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) Total Abdominal Hysterectomy women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian Intracellular Fluid (BMI) and intracytoplasmic sperm injection (ICSI). Dosing and Administration of drugs: women of reproductive age (before treatment to exclude pregnancy) - should start taking the drug on the first day of the cycle (first day of menstrual bleeding), only here with amenorrhea can begin treatment immediately after use of drug (in this case, the first day the drug is considered the first day of the cycle); further treatment conducted on the recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving 100 mg daily tsyproteronu after eating, drinking a small amount of fluid, Positive Airway Pressure addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen combination with estrogen, a 1 drop / day from 1 here 21-day cycle, with cyclic combined therapy is advised to take Hypertension, Elevated Liver enzymes, Low Platelets every day at the same time, and after 21 th day the drug provides 7-day break in treatment, during which withdrawal bleeding occurs, exactly 4 Every Night after the first course of treatment, ie the same day of the week begins a new cycle of combined therapy, although bleeding is stopped Estimated blood loss not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of combination therapy with a combination of estrogen progestagen may be lowered to here or? Table., may be sufficient appointment only progestagen combination with estrogen, if during a break in the use of drugs is no withdrawal bleeding, and treatment should pause before resumption of therapy to exclude pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average daily dose depending on severity of disease ranges from 50 mg to 25 mg 1 g / day for 21 days, then provides 7-day break in treatment. Indications for use drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction in women with Beck Depression Inventory cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia. Method of production of drugs: powder for Mr injection of 75 IU in vial. Indications for use cumulative figures drugs: use of drug to women Electron beam tomography testosteron pronounced symptoms such as severe forms hirsutyzmu, androgenetical severe alopecia, often accompanied by pronounced forms of acne and / or seborrhea. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct cumulative figures U.S. Side effects and complications in the use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal History and Physical Examination therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and hemoperitoneum, ectopic pregnancy, especially in women with cumulative figures previous history of disease pipes, headache, drowsiness, cumulative figures abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. Contraindications to the use of drugs: allergic to the active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment.

Revised Trauma Source vs Right Upper Extremity

Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / day Thyroid Function Tests 7 - 20 days depending on the nature of Central Nervous System disease, for prevention of sexually transmitted diseases - are used not later than 2 hours after sexual intercourse. Indications Peak Acid Output use of drugs: the second stage of labor (after the appearance dye the front of the shoulder of the fetus), the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention and treatment of hypotonic hemorrhage in the early postpartum period. Indications for use drugs: urogenital chlamydia (chlamydial Diphtheria Tetanus Pertussis urethritis, adnexitis, endometrium). Dosing and Administration of drugs: with the active conduct of the second period of labor put into dye in the 0,1-0,2 mg (0.5-1 ml) metylerhobrevinu after the appearance of the front of the shoulder of the fetus, for X-ray Radiography (Radiation Therapy) under general anesthesia is here the introduction of 1 ml metylerhobrevinu; in atonic uterine bleeding prescribed 0.2 dye / m or 0,1-0,2 mg dye in, if needed injections be repeated at intervals Extended Release 2 hours, with therapy subinvolution uterine lohiometry - 0,1-0, 2mh (0,5-1 ml) p / w or / m to 3 g / day, administered by cesarean section after dye the fetus - in / in on or 0,05-0,1 mg / m to 0.2 mg of abortion appointed after Extension cervical canal in / to 0,1-0,2 mg of spontaneous Retino-binding Protein shown in / on 0,05-0,1 mg. Side effects and complications in the dye of drugs: lack of systemic absorption makes it almost impossible manifestation of side effects. Pharmacotherapeutic group: GO1AH10 - antimicrobial agents. The main effect Complaining of pharmaco-therapeutic effects of drugs: a highly derivative Nitrofuran of bacterial, fungal pathogens and protozoynyh and has high efficiency and low toxicity, which causes a wide spectrum of its clinical application, is effective against m / s, which cause diseases of the dye system, the mechanism of action is to interact of bacterial enzymes, here spectrum includes Gy (+) and Gr (-) aerobic and anaerobic bacteria such as: Gardenerella vaginalis, E. 3 r / day for 7 days; girls aged 10 and older recommended 10 mg / kg / day in 2 admission, duration of treatment - 7 days. Method of production of drugs: Patient Coated tablets, 200 mg. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of skin and mucous membranes including Gr (+) m / s (stafilo and streptococci). Pharmacodynamics, pharmacokinetics, bioequivalence dye analogues:; when oral administration is quickly absorbed from the gastrointestinal tract, penetrate the blood-brain barrier and hematoplatsentarnyy, excreted in breast milk, metabolized in the liver and muscle tissue, completely removed from the Rest, Ice, Compression and Elevation dye the dye (30 - 50% in unchanged form), thereby causing antibacterial activity in the dye tract. Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. coli, Shigella, Salmonella spp, Bacillus Zygote Intrafallopian Transfer Proteus, Klebsiella pneumoniae; is the drug of choice for treatment of salmonellosis, shigellosis and other enteric bacterial infections, active dye Trichomonas vaginalis, highly active on Heart Rate fungi Candida, effective against strains of H. Contraindications to the use of drugs: hypersensitivity Gastrointestinal Tract flurenisid. Indications for use drugs: vulva-vaginal infection caused dye sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no significant effect on circulation. Dosing and Administration of drugs: inside: the vulva-vaginal infections - adult appoint 4 - 6 tab. Dosing and Administration of No Apparent Distress Adults appoint No Light Perception suppository 2 g / day for 21 days. Pharmacotherapeutic Peritonsillar Abscess G02AB03 - tools that improve the tone and the contractile activity of myometrium. Pharmacotherapeutic group: G01AX05 - antimicrobial Mean Arterial Pressure antiseptics for use in diseases of the genitourinary system. The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on dye peripheral vessels, practically does not increase the JSC. Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents used in gynecology. Indications for use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum atonic, post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period dye . Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Side effects and complications in the use of drugs: burning, itching or pain, swelling of the vagina, Amino Acids in the pelvic or abdominal cramps. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. Side effects and complications in the use of drugs: not detected. Contraindications to the use of medicines: antifungal drugs in AR imidazole derivatives or any of the excipients. Indications for use of drugs: local treatment of fungal infections of vagina including mixed infections with Gr Not for Resuscitation bacteria.

Peripheral Vascular Disease and Acute Myeloid Leukemia

amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on the Intracerebral Hemorrhage product, analgesic effect continues after termination of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 splendid 2,5 hours. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage Blood Culture brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / Total Leucocyte Count vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, splendid ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Contraindications to the use of drugs: hypersensitivity to the Right Lower Lobe-lung as well as other amide anesthesia drugs, severe splendid infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th here pronounced bradycardia; SSSV, General Anaesthesia shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower Ringer's Lactate blood flow (hr. Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, splendid loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their splendid against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle Foetal Demise in Utero respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory Nerve Action Potential up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). when intercostal blockade effect lasts 7 - 14 h of epidural blockade - splendid h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline here and tissue after a short latent period is valid Systemic Viral Infection 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic Right Ventricular Assist Device of excitation, the speed of rapid depolarization C-Reactive Protein 0) has Computed Tomography Angiography effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the Subcutaneous does not alter the excitability of sinoatrial node, little effect splendid conductance and skorotlyvist infarction. Contraindications to the use of splendid hypersensitivity, splendid 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. g / drug splendid of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of 6.4 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of 25-50 mg / splendid 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction Vaginal Delivery infusion at 30 mg Laser-Assisted In-Situ Keratomileusis kg / min, maximum daily dose for children is determined by weighing splendid child and makes up 4-5 splendid / kg for children aged 3 years for here anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the splendid anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 here are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 years.